VIM and colorectal carcinoma: Similarly, patient-derived CRC organoids challenged with iPolyP underwent a significant increase in Vimentin (Vim), MMP2, α-SMA, COL1A1, and CTGF, which was dampened by blocking the TRPM8 receptor (Figure 1B, and Supplementary Figure S4A).